"No swift action" on US CBD regulation after FDA comments, warns analyst

Home › "No swift action" on US CBD regulation after FDA comments, warns analyst

CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.

12.05	Kline Analysts Detail the Medical Dispensing Skin Care Market
12.05	Glo30 Starts 2024 Strong with 60% Growth
12.05	Zevo On-Body Repellent Teams with American Hiking Society To Provide Bug Bite Defense
12.05	L\'Oréals Brand Value Soars to $13.4 Billion
12.05	Spate Unveils the Top Sustainability Trends Cycling Google Searches
12.05	Oh K! is the Most Searched Beauty Brand in the World: Cosmetify
12.05	Zahawi confirms nearly 5m paid for tax error
12.05	Shein suppliers still work 75-hour weeks - report
More »

je.st